Implantable vascular device comprising a bioabsorbable frame

ABSTRACT

A multiple-sided valve for implantation within a body vessel comprising a frame comprising a bioabsorbable material is provided. The devices can be pushed from a delivery catheter into the lumen of a duct or vessel and may include one or more barbs for anchoring purposes. A full or partial covering of fabric or other flexible material, or a bioabsorbable material, including a collagen-based material such as small intestinal submucosa (SIS), may be attached to the frame to form an occlusion device, a graft, or an implantable, intraluminal valve such as for correcting incompetent veins in the lower legs and feet.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of, and fully incorporates byreference, U.S. utility patent application Ser. No. 09/777,091, filedFeb. 5, 2001, published as U.S. 2001-0039450 A1 on Nov. 8, 2001, whichclaims priority to Provisional U.S. Patent Application Ser. No.60/180,002, filed Feb. 3, 2000 and regular utility application Ser. No.09/324,382, filed Jun. 2, 1999, and issued as U.S. Pat. No. 6,200,336 onMar. 13, 2001.

BACKGROUND

1. Technical Field

This invention relates to medical devices, more particularly, tointraluminal devices.

2. Background Information

As minimally invasive techniques and instruments for placement ofintraluminal devices have developed over recent years, the number andtypes of treatment devices have proliferated as well. Stents, stentgrafts, occlusion devices, artificial valves, shunts, etc., haveprovided successful treatment for a number of conditions that heretoforerequired surgery or lacked an adequate solution altogether. Minimallyinvasive intravascular devices especially have become popular with theintroduction of coronary stents to the U.S. market in the early 1990s.Coronary and peripheral stents have been proven to provide a superiormeans of maintaining vessel patency. In addition, they have subsequentlybeen used as filter, occluders, or in conjunction with grafts as arepair for abdominal aortic aneurysm, with fibers or other materials asocclusion devices, and as an intraluminal support for artificial valves,among other uses.

Some of the chief goals in designing stents and related devices includeproviding sufficient radial strength to supply sufficient force to thevessel and prevent device migration. An additional concern in peripheraluse, is having a stent that is resistant to external compression.Self-expanding stents are superior in this regard to balloon expandablestents which are more popular for coronary use. The challenge isdesigning a device that can be delivered intraluminally to the target,while still being capable of adequate expansion. Self-expanding stentsusually require larger struts than balloon expandable stents, thusincreasing their profile. When used with fabric or other coverings thatrequire being folded for placement into a delivery catheter, the problemis compounded.

There exists a need to have a basic stent, including a fabric orbiomaterial covering, that is capable of being delivered with a lowprofile, while still having a sufficient expansion ratio to permitimplantation in larger vessels, if desired, while being stable,self-centering, and capable of conforming to the shape of the vessel.There is a further need to have a intraluminal valve that can bedeployed in vessels to replace or augment incompetent native valves,such as in the lower extremity venous system to treat patients withvenous valve insufficiency. Such a valve should closely simulate thenormal functioning valve and be capable of permanent implantation withexcellent biocompatibility.

SUMMARY OF THE INVENTION

The foregoing problems are solved and a technical advance is achieved inan illustrative implantable valve that is deployed within a bodilypassage, such as a blood vessel or the heart, to regulate or augment thenormal flow of blood or other bodily fluids. The valve includes acovering having oppositely facing curvilinear-shaped surfaces (upper andlower) against which fluid traveling in a first or second directionwithin the bodily passage exerts force to at least partially open orclose the valve. At least one outer edge of the covering resilientlyengages and exerts force against the wall of the vessel and has arcuateshape that provides at least a partial seal against the wall.

In one aspect of the invention, the covering comprises a plurality ofleaflets, each leaflet having a body extending from a wall-engagingouter edge to a free edge which is cooperable with one or more opposingleaflets to prevent flow in one direction, such as retrograde flow,while at least a portion of the leaflets having sufficient flexibility,when in situ to move apart, thereby creating a valve orifice thatpermits flow in the opposite direction, such as normal blood flow. Theouter edge of each leaflet is adapted to engage and resilient exertforce against a wall of the bodily passage such that it extends in botha longitudinal and circumferential directions along the vessel wall toat least partially seal a portion of the vessel lumen, while the freeedge of each leaflet traverses the passageway across the diameter of thevessel.

In another aspect of the invention, the valve includes a frame that iscovered by a piece of biocompatible material, preferably anExtracellular Collagen Matrix (ECM) such as small intestinal submucosa(SIS) or another type of submucosal-derived tissue. Other potentialbiomaterials include allographs such as harvested native valve tissue.The material is slit or otherwise provided with an opening along oneaxis to form two triangular valve leaflets over a four-sided frame. Inthe deployed configuration, the leaflets are forced open by normal bloodflow and subsequently close together in the presence of backflow to helpeliminate reflux. Other configurations include a two-leaflet valvehaving an oval or elliptically shaped frame, and valves having three ormore legs and associated leaflets, which provide a better distributionof the load exerted by the column of fluid acting on the leaflets.

In still another aspect of the invention, the frame of the device ismodified by placing one or more of the bends under tension which resultsin the frame assuming a second shape that has superior characteristicsof placement within the vessel. One method of adjusting the shapeincludes forming the bends in the wire at an initial angle, e.g., 150□,that is larger than the desired final angle, e.g., 90□ for a four-sidedvalve, so when the frame is constrained into the final configuration,the sides are arcuate and bow outward slightly. The curvature of thesides allows the sides to better conform to the rounded countours of thevessel wall when the valve is deployed. In devices having a full orpartial covering of material over the frame, a second method ofmodifying the shape is to use the material to constrain the frame in oneaxis. One such embodiment includes a four-sided valve with twotriangular-shaped halves of material, such as SIS, where the materialconstrains the frame in a diamond shape. This puts the bend of the frameunder stress or tension which permits better positioning within thevessel. It also allows the diagonal axis of the frame with the slit ororifice to be adjusted to the optimal length to properly size the framefor the vessel such that the leaflets open to allow sufficient flow, butdo not open to such a degree that they contact the vessel wall. Thepotential benefits of both adding tension to the bends to bow the sidesand constraining the frame into a diamond shape using the covering, canbe combined in a single embodiment or employed separately.

In still another aspect of the present invention, the device includes aframe that in one embodiment, is formed from a single piece of wire orother material having a plurality of sides and bends eachinterconnecting adjacent sides. The bends can be coils, fillets, orother configurations to reduce stress and improve fatigue properties.The single piece of wire is preferably joined by an attachmentmechanism, such as a piece of cannula and solder, to form a closedcircumference frame. The device has a first configuration wherein thesides and bends generally lie within a single, flat plane. In anembodiment having four equal sides, the frame is folded into a secondconfiguration where opposite bends are brought in closer proximity toone another toward one end of the device, while the other opposite endsare folded in closer proximity together toward the opposite end of thedevice. In the second configuration, the device becomes a self-expandingstent. In a third configuration, the device is compressed into adelivery device, such as a catheter, such that the sides are generallybeside one another. While the preferred embodiment is four-sided, otherpolygonal shapes can be used as well. The frame can either be formedinto a generally flat configuration, or into the serpentineconfiguration for deployment. Besides rounded wire, the frame cancomprise wires of other cross-sectional shapes (e.g., oval, delta,D-shape), or flat wire. Additionally, the frame can be molded from apolymer or composite material, or formed from a bioabsorbable materialsuch as polyglycolic acid and materials with similar properties. Anothermethod is to laser cut the frame out of a metal tube, such as stainlesssteel or nitinol. Still yet another method is to spot weld together, orotherwise attach, a series of separate struts that become the sides of aclosed frame. In further alternative embodiments, the frame can be leftwith one or more open gaps that are bridged by the material stretchedover the remainder of the frame. The frame can also be formed integrallywith the covering, typically as a thickened or strengthened edge portionthat gives the device sufficient rigidity to allow it to assume thedeployed configuration in the vessel. To prevent the frame from radiallyexpanding within the vessel beyond the point which would be consideredsafe or desirable, the device can be formed into the serpentineconfiguration and a circumferentially constraining mechanism, such as atether, strut, sleeve, etc., placed around the device, or built into theframe, to expand or unfold during deployment of the device to limit itsexpansion to a given diameter, such as that which is slightly largerthan the vessel into which it is placed to allow anchoring, but notpermit the device to exert to great a force on the vessel wall.

In another aspect of the present invention, one or more barbs can beattached to the frame for anchoring the device in the lumen of a vessel.The barbs can be extensions of the single piece of wire or othermaterial comprising the frame, or they can represent a second piece ofmaterial that is separately attached to the frame by a separateattachment mechanism. An elongated barb can be used to connectadditional devices with the second and subsequent frames attached to thebarb in a similar manner. Additional barbs can be secured to the devicefrom cannulae placed over the frame. In embodiments in which the frameis formed as a single piece, such as when cut from a sheet of materialor injection molded, the barbs can be formed as integral extensions ofthe frame.

In still another aspect of the present invention, a covering, which canbe a flexible synthetic material such as DACRON, or expandedpolytetrafluorethylene (ePTFE), or a natural or collagen-based material,such as an allographic tissue (such as valvular material) or axenographic implant (such as SIS), can be attached to the device withsutures or other means to partially, completely, or selectively restrictfluid flow. When the covering extends over the entire aperture of theframe, the frame formed into the second configuration functions as anvascular occlusion device that once deployed, is capable of almostimmediately occluding an artery. An artificial valve, such as that usedin the lower legs and feet to correct incompetent veins, can be made bycovering half of the frame aperture with a triangular piece of material.The artificial valve traps retrograde blood flow and seals the lumen,while normal blood flow is permitted to travel through the device. Inrelated embodiments, the device can be used to form a stent graft forrepairing damaged or diseased vessels. In a first stent graftembodiment, a pair of covered frames or stent adaptors are used tosecure a tubular graft prosthesis at either end and seal the vessel.Each stent adaptor has an opening through which the graft prosthesis isplaced and an elongated barb is attached to both frames. In anotherstent graft embodiment, one or more frames in the second configurationare used inside a sleeve to secure the device to a vessel wall.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 depicts a top view of one exemplary embodiment of the presentinvention;

FIG. 2 depicts a pictorial view of the embodiment of FIG. 1;

FIGS. 3, 3A and 3B depict a top view and enlarged, partialcross-sectional views of a second exemplary embodiment of the presentinvention;

FIG. 4 depicts a side view of the embodiment of FIG. 3 deployed in avessel;

FIG. 5 depicts a enlarged partial view of the embodiment of FIG. 1;

FIG. 6 depicts a partially-sectioned side view of the embodiment of FIG.1 inside a delivery system;

FIG. 7 depicts a top view of a third embodiment of the presentinvention;

FIG. 8 depicts a side view of the embodiment of FIG. 7 deployed in avessel;

FIGS. 9, 10 and 11 depict enlarged partial views of other embodiments ofthe present invention;

FIG. 12 depicts a top view of a fourth embodiment of the presentinvention;

FIGS. 13 and 14 depicts side views of the embodiment of FIG. 12;

FIG. 15 depicts a top view of a fifth embodiment of the presentinvention;

FIG. 16 depicts a side view of the embodiment of FIG. 15;

FIG. 17 depicts a side view of a sixth embodiment of the presentinvention;

FIG. 18 depicts an enlarged pictorial view of a seventh embodiment ofthe present invention;

FIG. 19 depicts a top view of an eighth embodiment of the presentinvention;

FIG. 20 depicts a top view of a first embodiment of a multi-leafletintraluminal valve of the present invention;

FIG. 21 depicts a top view of a second embodiment of a multi-leafletintraluminal valve;

FIG. 21A depicts a partial top view of another embodiment of leaflets ofthe present invention;

FIG. 21B depicts a top view of another embodiment of leaflet of thepresent invention;

FIGS. 22 and 23 depict side views of the embodiment of FIG. 21 whendeployed in a vessel;

FIGS. 24 and 25 depict pictorial views of the embodiments of FIG. 21when deployed in a vessel;

FIGS. 26 and 26A depict the method of attaching the covering to theembodiment of FIG. 21;

FIG. 27 depicts a pictorial view of the basic valve of FIG. 21 upondeployment with an alternative leaflet embodiment;

FIGS. 28, 29, 30 and 31 depict top views of selected embodiments of thepresent invention, made using the method shown in FIG. 28;

FIG. 32 depicts a pictorial view of an embodiment of a stent graft thatincludes stent adaptors of the present invention;

FIG. 33 depicts a delivery system for deploying an embodiment of thepresent invention; and

FIG. 34 depicts a pictorial view of the present invention havingreturned to the first configuration following formation into the secondconfiguration;

FIGS. 35 and 36 depict top views of a three-leg valve embodiment of thepresent invention, before and after being constrained;

FIG. 37 depicts a pictorial view of the embodiment of FIG. 35 in thedeployed configuration;

FIGS. 38 and 39 depict top views of four-leg valve embodiments of thepresent invention, before and after being constrained;

FIG. 40 depicts a pictorial view of the embodiment of FIG. 38 in thedeployed configuration;

FIG. 41 depicts a top view of a frame formed from a sheet of material;

FIG. 41A depicts a detail view of the embodiment of FIG. 41;

FIG. 42 depicts a top view of a third embodiment of an intraluminalvalve;

FIG. 43 depicts a pictorial view a frame embodiment formed into adeployed configuration;

FIG. 44 depicts a top view of an embodiment of implantable valve havingan integrally formed frame and covering;

FIG. 45 depicts a cross-sectional view taken along line 45-45 of FIG.44;

FIG. 46 depicts a cross-sectional view of a second embodiment of valvehaving an integrally formed frame and covering;

FIG. 47 depicts a top view of an intraluminal valve embodiment having anopen frame;

FIGS. 48 and 49 depict a pictorial views of an intraluminal valveembodiments that includes a circumferentially constraining mechanism;and

FIG. 50 depicts a top view of the embodiment of FIG. 22.

DETAILED DESCRIPTION OF THE DRAWINGS AND THE PRESENTLY PREFERREDEMBODIMENTS

The invention is further illustrated by the following (preceding)pictorial embodiments, which in no way should be construed as furtherlimiting. The present invention specifically contemplates otherembodiments not illustrated but intended to be included in the appendedclaims. FIGS. 1-11,18-19 are directed to a basic stent frame; FIGS.12-14 are directed to a single-leaflet valve; FIGS. 15-16 are directedto an occluder (or filter); FIGS. 17 and 32 are directed to a stentadaptor for a stent graft, FIG. 20-27, 35-40, 42-50 are directed to amulti-leaf valve; and FIG. 28-31 are directed to a constrained framewhich can be used to form any of the other embodiments.

FIG. 1 depicts a top view of one embodiment of the medical device 10 ofthe present invention comprising a frame 11 of resilient material,preferably metal wire made of stainless steel or a superelastic alloy(e.g., nitinol). While round wire is depicted in each of the embodimentsshown herein, other types, e.g., flat, square, triangular, D-shaped,delta-shaped, etc. may be used to form the frame. In the illustrativeembodiment, the frame comprises a closed circumference 62 of a singlepiece 59 of material that is formed into a device 10 having a pluralityof sides 13 interconnected by a series of bends 12. The depictedembodiment includes four sides 13 of approximately equal length.Alternative embodiments include forming a frame into any polygonalshape, for example a pentagon, hexagon, octagon, etc. One alternativeembodiment is shown in FIG. 19 that includes a four-sided frame 11having the general shape of a kite with two adjacent longer sides 66 andtwo adjacent shorter sides 67. In the embodiment of FIG. 1, the bends 12interconnecting the sides 13 comprise a coil 14 of approximately one anda quarter turns. The coil bend produces superior bending fatiguecharacteristics than that of a simple bend 40, as shown in FIG. 9, whenthe frame is formed from stainless steel and most other standardmaterials. The embodiment of FIG. 9 may be more appropriate, however, ifthe frame is formed from nitinol (NiTi) or other superelastic alloys, asforming certain type of bends, such as coil 14, may actually decreasefatigue life of a device of superelastic materials. Therefore, the bend12 should be of a structure that minimizes bending fatigue. Alternativebend 12 embodiments include an outward-projecting fillet 41 as shown inFIG. 10, and an inward-projecting fillet 42 comprising a series ofcurves 63, as shown in FIG. 11. Fillets are well known in the stent artas a means to reduce stresses in bends. By having the fillet extendinward as depicted in FIG. 11, there is less potential trauma to thevessel wall.

When using stainless steel wire, the size of the wire which should beselected depends on the size of device and the application. An occlusiondevice, for example, preferably uses 0.010″ wire for a 10 mm squareframe, while 0.014″ and 0.016″ wire would be used for 20 mm and 30 mmframes, respectively. Wire that is too stiff can damage the vessel, notconform well to the vessel wall, and increase the profile of the devicewhen loaded in the delivery system prior to deployment.

Returning to FIG. 1, the single piece 59 of material comprising theframe 11 is formed into the closed circumference 62 by securing thefirst and second ends 60,61 with an attachment mechanism 15 such as apiece of metal cannula. The ends 60,61 of the single piece 59 are theninserted into the cannula 15 and secured with solder 25, a weld,adhesive, or crimping to form the closed frame 11. The ends 60,61 of thesingle piece 59 can be joined directly without addition of a cannula 15,such as by soldering, welding, or other methods to join ends 61 and 62.Besides joining the wire, the frame could be fabricated as a singlepiece of material 59, by stamping or cutting the frame 11 from anothersheet (e.g., with a laser), fabricating from a mold, or some similarmethod of producing a unitary frame.

The device 10 depicted in FIG. 1 is shown in its first configuration 35whereby all four bends 20,21,22,23 and each of the sides 13 generallylie within a single flat plane. To resiliently reshape the device 10into a second configuration 36, shown in FIG. 2, the frame 11 of FIG. 1is folded twice, first along one diagonal axis 94 with opposite bends 20and 21 being brought into closer proximity, followed by opposite bends22 and 23 being folded together and brought into closer proximity in theopposite direction. The second configuration 36, depicted in FIG. 2, hastwo opposite bends 20,21 oriented at the first end 68 of the device 10,while the other opposite bends 22,23 are oriented at the second end 69of the device 10 and rotated approximately 90□ with respect to bends 20and 21 when viewed in cross-section. The medical device in the secondconfiguration 36 can be used as a stent 44 to maintain an open lumen 34in a vessel 33, such as a vein, artery, or duct. The bending stressesintroduced to the frame 11 by the first and second folds required toform the device 10 into the second configuration 36, apply forceradially outward against the vessel wall 70 to hold the device 10 inplace and prevent vessel closure. Absent any significant plasticdeformation occurring during folding and deployment, the device in thesecond configuration 36 when not with the vessel or other constrainingmeans, will at least partially return to the first configuration 25,although some deformation can occur as depicted in FIG. 34, depending onthe material used. It is possible to plastically form the stent intothis configuration which represents an intermediate condition betweenthe first configuration (which it also can obtain) and the secondconfiguration. It is also possible to plastically deform the device 10into the second configuration 36, such that it does not unfold whenrestraint is removed. This might be particularly desired if the deviceis made from nitinol or a superelastic alloy.

The standard method of deploying the medical device 10 in a vessel 33,depicted in FIG. 6, involves resiliently forming the frame 11 into athird configuration 37 to load into a delivery device 26, such as acatheter. In the third configuration 37 the adjacent sides 13 aregenerally beside each other in close proximity extending generally alongthe same axis. To advance and deploy the device from the distal end 28of the delivery catheter 26, a pusher 27 is placed into the catheterlumen 29. When the device 10 is fully deployed, it assumes the secondconfiguration 36 within the vessel as depicted in FIG. 2. The sides 13of the frame, being made of resilient material, conform to the shape ofthe vessel wall 70 such that when viewed on end, the device 10 has acircular appearance when deployed in a round vessel. As a result, sides13 are arcuate or slightly bowed out to better conform to the vesselwall.

A second embodiment of the present invention is depicted in FIG. 3wherein one or more barbs 16 are included to anchor the device 10following deployment. As understood, a barb can be a wire, hook, or anystructure attached to the frame and so configured as to be able toanchor the device 10 within a lumen. The illustrative embodimentincludes a first barb 16 with up to three other barbs 17,71,72,indicated in dashed lines, representing alternative embodiments. Asdepicted in detail view A of FIG. 3, the barb combination 38 thatcomprises barbs 17 and 18, each barb is an extension of the single piece59 of material of the frame 11 beyond the closed circumference 59. Theattachment cannula 15 secures and closes the single piece 59 of materialinto the frame 11 as previously described, while the first and secondends 60,61 thereof, extend from the cannula 15, running generallyparallel with the side 13 of the frame 11 from which they extend, eachpreferably terminating around or slightly beyond respective bends 20,23.To facilitate anchoring, the distal end 19 of the barb 16 in theillustrative embodiment contains a bend or hook.

Optionally, the tip of the distal end 19 can be ground to a sharpenedpoint for better tissue penetration. To add a third and fourth barb asshown, a double ended barb 39 comprising barbs 71 and 72 is attached tothe opposite side 13 as defined by bends 21 and 22. Unlike barbcombination 38, the double barb 39, as shown in detail view B of FIG. 3,comprises a piece of wire, usually the length of barb combination 38,that is separate from the single piece 59 comprising the main frame 11.It is secured to the frame by attachment mechanism 15 using the methodsdescribed for FIG. 1. FIG. 4 depicts barb 17 (and 18) engaging thevessel wall 70 while the device 10 is in the second, deployedconfiguration 36. While this embodiment describes up to a four barbsystem, more than four can be used.

FIG. 7 depicts a top view of a third embodiment of the present inventionin the first configuration 35 that includes a plurality of frames 11attached in series. In the illustrative embodiment, a first frame 30 andsecond frame 31 are attached by a barb 16 that is secured to each frameby their respective attachment mechanisms 15. The barb 16 can be adouble-ended barb 39 as shown in FIG. 3 (and detail view B) that isseparate from the single pieces 59 comprising frames 30 and 31, or thebarb may represent a long extended end of the one of the single pieces59 as shown in detail view A of FIG. 3. Further frames, such as thirdframe 32 shown in dashed lines, can be added by merely extending thelength of the barb 16. FIG. 8 depicts a side view of the embodiment ofFIG. 7 in the second configuration 36 as deployed in a vessel 33.

FIGS. 12-18 depict embodiments of the present invention in which acovering 45 comprising a sheet of fabric, collagen (such as smallintestinal submucosa), or other flexible material is attached to theframe 11 by means of sutures 50, adhesive, heat sealing, A weaving@together, crosslinking, or other known means. FIG. 12 depicts a top viewof a fourth embodiment of the present invention while in the firstconfiguration 35, in which the covering 45 is a partial covering 58,triangular in shape, that extends over approximately half of theaperture 56 of the frame 11. When formed into the second configuration36 as shown in FIGS. 13-14, the device 10 can act as an artificial valve43 such as the type used to correct valvular incompetence. FIG. 13depicts the valve 43 in the open configuration 48. In this state, thepartial covering 58 has been displaced toward the vessel wall 70 due topositive fluid pressure or flow in a first direction 46, e.g., normalvenous blood flow, thereby opening a passageway 65 through the frame 11and the lumen 34 of the vessel 33. As the muscles relax, producing flowin a second, opposite direction 47, e.g., retrograde blood flow 47, asshown in FIG. 14, the partial covering 58 acts as a normal valve bycatching the backward flowing blood and closing the lumen 34 of thevessel. In the case of the artificial valve 43, the partial covering 58is forced against the vessel wall to seal off the passageway 65, unlikea normal venous valve which has two leaflets, which are forced togetherduring retrograde flow. Both the artificial valve 43 of the illustrativeembodiment and the normal venous valve, have a curved structure or cuspthat facilitates the capture of the blood and subsequent closure. Inaddition to the triangular covering, other possible configurations ofthe partial covering 58 that result in the cupping or trapping of fluidin one direction can be used.

Selecting the correct size of valve for the vessel ensures that thepartial covering 58 properly seals against the vessel wall 70. If thelumen 34 of the vessel is too large for the device 10, there will beretrograde leakage around the partial covering 58.

FIG. 15 depicts a top view of a fifth embodiment of the presentinvention in the first configuration 35, whereby there is a fullcovering 57 that generally covers the entire aperture 56 of the frame11. When the device 10 is formed into the second configuration 36, asdepicted in FIG. 16, it becomes useful as an occlusion device 51 toocclude a duct or vessel, close a shunt, repair a defect, or otherapplication where complete or substantially complete prevention of flowis desired. As an intravascular device, studies in swine have shownocclusion to occur almost immediately when deployed in an artery or theaorta with autopsy specimens showing that thrombus and fibrin which hadfilled the space around the device. The design of the present inventionpermits it to be used successfully in large vessels such as the aorta.Generally, the occlusion device should have side 13 lengths that are atleast around 50% or larger than the vessel diameter in which they are tobe implanted.

FIGS. 17-18 depict two embodiments of the present invention in which thedevice 10 functions as a stent graft 75 to repair a damaged or diseasedvessel, such as due to formation of an aneurysm. FIG. 17 shows a stentgraft 75 having a tubular graft prosthesis 54 that is held in place by apair of frames 11 that function as stent adaptors 52,53. Each stentadaptor 52,53 has a covering attached to each of the frame sides 13which includes a central opening 55 through which the graft prosthesis54 is placed and held in place by friction or attachment to preventmigration. One method of preventing migration is placement of a stentadaptor 52,53 according to the present invention at each end andsuturing the graft prosthesis 54 to the covering of the stent adaptors52,53. The stent adaptors 52,53 provide a means to seal blood flow whilecentering the graft prosthesis in the vessel. A long double-ended barb39 connects to each stent adaptor 52,53 and assists to further anchorthe stent graft 75. In the embodiment depicted in FIG. 18, the covering45 comprises a outer sleeve 64 that is held in place by first and second30,31 frames that function as stents 44 to hold and seal the sleeve 64against a vessel wall and maintain an open passageway 65. In theillustrative embodiment, the stents 44 are secured to the graft sleeve64 by sutures 50 that are optionally anchored to the coils 14 of thebends 12. If the embodiment of FIG. 18 is used in smaller vessels, asingle frame 11 can be used at each end of the stent graft 75. Anotherstent graft 75 embodiment is depicted in FIG. 32 for repairing a vesseldefect 97, such as an aneurysm in a bifurcated vessel. The stent adaptor52 of the present invention is placed in the common vessel 96 such asthe abdominal aorta. Two tubular grafts 54 are secured within anaperture 55 in the covering 45 of the frame 11 by one or more internalstent adapters 102, or another type of self-expanding stent, that biasthe opening of the grafts 54 against the surrounding covering 45 toprovide an adequate seal. Each leg 98,99 of the stent graft prosthesis75 transverses the vessel defect 97 and feeds into their respectivevessel branches 100,101 such the right and left common iliac arteries.As with the embodiment of FIG. 17, a second stent adapter 53 can be usedto anchor the other end of the tubular graft 54 in each vessel branch100,101.

FIGS. 20-27 and 35-41 depict embodiments of present inventions in whichthe device 10 comprises an implantable valve having multiple leaflets 25that act together to regulate and augment the flow of fluid through aduct or vessel 33, or within the heart to treat patients with damaged ordiseased heart valves. The covering 45 of each of these embodimentsincludes one or a series of partial coverings 58 that form the leaflets25 of the valve. As with the other embodiments, the covering 45 maycomprise a biomaterial or a synthetic material. While DACRON, expandedpolytetrafluoroethylene (ePTFE), or other synthetic biocompatiblematerials can be used to fabricate the covering 45, a naturallyoccurring biomaterial, such as collagen, is highly desirable,particularly a specially derived collagen material known as anextracellular matrix (ECM), such as small intestinal submucosa (SIS).Besides SIS, examples of ECM=s include pericardium, stomach submucosa,liver basement membrane, urinary bladder submucosa, tissue mucosa, anddura mater. SIS is particularly useful, and can be made in the fashiondescribed in Badylak et al., U.S. Pat. No. 4,902,508; IntestinalCollagen Layer described in U.S. Pat. No. 5,733,337 to Carr and in 17Nature Biotechnology 1083 (November 1999); Cook et al., WIPO PublicationWO 98/22158, dated 28 May 1998, which is the published application ofPCT/US97/14855. Irrespective of the origin of the valve material(synthetic versus naturally occurring), the valve material can be madethicker by making multilaminate constructs, for example SIS constructsas described in U.S. Pat. Nos. 5,968,096; 5,955,110; 5,885,619; and5,711,969. Animal data show that the SIS used in venous valves of thepresent invention can be replaced by native tissue in as little as amonth=s time. In addition to xenogenic biomaterials, such as SIS,autologous tissue can be harvested as well, for use in forming theleaflets of the valve. Additionally Elastin or Elastin Like Polypetides(ELPs) and the like offer potential as a material to fabricate thecovering or frame to form a device with exceptional biocompatibility.Another alternative would be to used allographs such as harvested nativevalve tissue. Such tissue is commercially available in a cryopreservedstate.

To more completely discuss and understand the multi-leaflet valve 43embodiments of FIGS. 20-27,35-41, it is useful to now add certainsupplemental terminology which in some instances, could be applied tothe embodiments depicted in the earlier figures. In the illustrativemulti-leaflet embodiments, the valve 43 is divided into a plurality oflegs 113, each of which further comprises a leaflet 25. To anchor,support, and provide the proper orientation of the leaflets 25, aseparate or integral frame 11 is included, such as the wire frame 11depicted in FIG. 1. Ideally, the wire used to construct the frame ismade of a resilient material such as 302,304 stainless steel; however, awide variety of other metals, polymers, or other materials are possible.It is possible for the frame to be made of the same material as theleaflets 25. One other example of a suitable frame material would be asuperelastic alloy such as nitinol (NiTi). Resiliency of the frame 11,which provides radial expandability to the valve 43 when in the secondconfiguration 36 for deployment, is not necessarily an essentialproperty of the frame. For example, optional barbs 16 can provide themeans to anchor the valve 43 after delivery, even if the valve 43 lackssufficient expansile force to anchor itself against the vessel wall.Additionally, the frame can comprise a ductile material with the device10 being designed to be balloon expandable within the vessel.

Typically, when used as a valve to correct venous insufficiency in thelower extremities, the valve 43 in situ comprises a plurality of bends12 of the frame, that provide the majority of the outward radial forcethat helps anchor the device to vessel wall 70, as depicted in FIGS.22-27. When deployed, the frame assumes the undulating or serpentineconfiguration characteristic of the invention with a first series ofbends 115 of the first or proximal end alternating with a second seriesof bends 116 of the second or distal end, with the second or distalbends 116 being located at the bottom of the valve distal to the heartand the first or proximal bends 115 being located at the top of thevalve proximal to the heart. It should be understood that the valve canassume other orientations, depending on the particular clinical use, andthus, any directional labels used herein (>distal=, >top=, etc.) aremerely for reference purposes. The leaflet 25, which generally coversthe valve leg 113 and therefore, assumes the same roughlytriangular >U=or >V=shape of that portion of the frame 11 perimeter,includes an resilient arcuate outer edge 112 that conforms to and/orseals with the contours of the vessel wall 70, and an inner edge 11 thattraverses the vessel lumen 34. The central portion or body 156 of theleaflet 25 extends inward from the vessel wall 70 and outer edge 112 inan oblique direction toward the first end 68 of the valve 43 where itterminates at the inner edge 111 thereof. The valve leaflets that comein contact with the vessel wall can also be arcuate as the supportingframe to better conform to and seal wit the vessel wall. The leaflets 25assume a curvilinear shape when in the deployed configuration 36. Theportion of the body 156 proximate the inner edge 111 is sufficientlyflexible such that is can move in and out of contact with the inner edge111 the opposite or other leaflets 25; however, the remainder of thebody 156, particular that near the outer edge 112 or second end 69 ofthe device 10, can be made less flexible or even rigid in someinstances, essentially functioning more for support, similar to thefunction of the frame 11, rather than to cooperate with other leaflet(s)25. FIGS. 20-27 depict the present invention as an implantable,intraluminal, vascular adapted for use as a implantable multi-leafletvalve 43 including a stent 44 or frame 11 with at least a partialcovering 58. The covering comprises a first and a second valve leaflets78,79 that at least partially seal the aperture 56 within the frame 11while the valve 43 is in the deployed configuration 36 and forms theopening 117 or valve orifice which regulates the flow of fluid 46,47through the valve. FIG. 20 shows the device 10 in the first, generallyplanar configuration 35 where the frame 11 is generally rectangular orin particular square in shape. The partial covering 58 forming theleaflets 78,79 generally extends across the entire frame 11 with theaperture 56 comprising a slit 108 that extends across the first axis 94of the frame 11, the first axis being defined as traversing diagonallyopposite bends (22 and 23 in this example) that are in line with thevalve orifice 117 that forms the valve 43. The covering 45 is thereforedivided into at least first and second portions (making it a partialcovering 58) which define the first and second valve leaflets 78,79. Toform the leaflets 78,79, a complete covering 45 can be slit open alongthe axis after it is affixed to the frame, or at least first and secondadjacent triangular portions (partial coverings 58) can be separatelyattached, eliminating the need for mechanically forming a slit 108. Inthe embodiment of FIG. 20, the slit 108 is made in the covering 45 suchthat the slit terminates a few millimeters from each of the corner bends22,23, creating a pair of corner gaps 155, thereby eliminating two ofthe most likely sources of leakage around the valve 43. In theillustrative embodiments, the outer edge 112 of the partial covering 58that comprises the leaflet 25 is stretched over the frame 11 comprisingthe valve leg 113 and sutured or otherwise attached as disclosed herein.The leaflet 25 is secured in place such that the material is fairlytaut, such that when the valve 43 is situated in the vessel 33 and itsdiameter constrained to slightly less than the valve width 146, theleaflet 25 assumes a relatively loose configuration that gives it theability to flex and invert its shape, depending on the direction offluid flow. The inner edge 111 of the leaflet 25 is generally free andunattached to the frame and generally extends between the bends 22 and23 (the bends 115 of the first end) of the valve leg 113. The inner edge111 may be reinforced by some means, such as additional material or thinwire, that still would allow it to be sufficiently pliable to be able toseal against another leaflet 25 when retrograde flow 47 forces theleaflets 78,79 together. The leaflet 25 is sized and shaped such thatthe inner edge 111 of one leaflet 78 can meet or overlap with the inneredge 111 of the opposing leaflet 79 (or leaflets, e.g., 119,120), exceptwhen degree of normal, positive flow 46 is sufficient to force theleaflets 25 open to permit fluid passage therethrough.

The embodiments of FIGS. 21-27 are configured into an elongated diamondshape 153 in the planar configuration 35 with the distance between thetwo bends 22,23 aligned with the valve orifice 117 and first axis 94being less than the distance between bends 20 and 21 along the second,perpendicular axis 95. This diamond configuration 153 can beaccomplished by forming the frame 11 into that particular shape, orconstraining a square frame into a diamond shape 153, which will bediscussed later. By configuring the valve 43 into the diamond shape 153,the valve legs 127,128 become more elongated in shape, which can helpadd stability when positioning the device 10 during deployment, providesmore surface area to receive retrograde flow, and more closely mimics anatural venous valve. In the deployed configuration 36 of the embodimentof FIG. 21, which is shown in FIGS. 22-25, the valve leaflets 78,79 areforced apart by the normal pulsatile blood flow 46 (FIGS. 22,24). Therespective valve leaflets 78,79 naturally move back into closerproximity following the pulse of blood. Retrograde blood flow 47 forcesthe valve leaflets 78,79 against one another, as depicted in FIGS. 23and 25 thereby closing off the lumen 34 of the vessel 33 and the valveorifice 117.

FIGS. 21A-21B depict embodiments of the valve 43 in which each leaflet78,79 includes a flap 77 of overhanging material along the slit edge 111to provide advantageous sealing dynamics when the valve 43 is in thedeployed configuration 36 as depicted in FIGS. 22-25. The flaps 77 aretypically formed by suturing two separate pieces of covering 45 materialto the frame such that the inner edge 111 is extendable over the slit108 and inner edge 111 of the adjacent leaflet 25. By overlapping withan adjacent flap 77 or leaflet 25, the flap 77 can provide additionalmeans to help seal the valve orifice 117. Two embodiments of leaflets 25with flaps 77 are shown. In FIG. 21A, the inner edge 111 is basicallystraight and extends over the first axis 94 of the frame 11. The flaps77 can be cut to create a corner gap 155 that covers and seals thecorner region around the bend 22,23. In the embodiment of FIG. 21B, theflap 77 is cut such that there is a notch 157 in the leaflet where theleaflet meets the corner bends 22,23. While these flaps 77 may providebenefit in certain embodiments, the optional flaps 77 shown in FIG. 21are not necessary to provide a good seal against backflow 47 if thevalve 43 and leaflets 25 are properly sized and configured.

FIGS. 26-26A depict one method of affixing a covering 45 comprising abiomaterial, such as SIS, to the frame 11 which has been constrainedusing a temporary constraining mechansim 121, such as a suture, toacheive the desired frame configuration. As shown in FIG. 26, thecovering 45 is cut larger than the frame 11 such that there is anoverhang 80 of material therearound, e.g, 5-10 mm. The frame 11 iscentered over the covering 45 and the overhang 80 is then folded overfrom one long side 142, with the other long side 143 subsequently beingfolded over the first. As shown in FIG. 26A, the covering 45 is suturedto the frame along one side 142, typically using forceps 158 and needle,thereby enclosing the frame 11 and the coiled eyelet 14 with theoverhang 80 along side 142. The covering 45 is sutured to the frame withresorbable or non-resorbable sutures 50 or some other suitable method ofattaching two layers of biomaterials can be used. In the case of SIS, asingle ply sheet, usually about 0.1 mm thick, is used in the hydratedcondition. In the illustrative embodiments, 7-0 Prolene suture is used,forming a knot at one bend (e.g., bend 20), then continuing to the nextbend (e.g., 22) with a running suture 50, penetrating the layers of SISaround the frame at about 1-2 mm intervals with loops formed to hold thesuture 50 in place. When the next coil turn 14 is reached, several knotsare formed therethrough, and the running suture 50 continues to the nextcoil turn 14. If barbs are present, such as shown in the embodiment ofFIG. 21, the suture 50 is kept inside of the barbs 16 located about eachcoil turn 14. In the illustrative example, the covering 45 is affixed tothe frame 11 such that one side of the overhang 80 is not sutured overthe other side in order to maintain the free edge of the overhang 80,although the alternative condition would be an acceptable embodiment.Alternative attachment methods include, but are not limited to, use of abiological adhesive, a cross-linking agent, heat welding, crimping, andpressure welding. For synthetic coverings, other similar methods ofjoining or attaching materials are available which are known in themedical arts. The covering 45, whether made from a biomaterial orsynthetic material, can be altered in ways that improve its function,for example, by applying a coating of pharmacologically active materialssuch as heparin or cytokines, providing a thin external cellular layer,e.g., endothelial cells, or adding a hydrophilic material or othertreatment to change the surface properties.

Once the covering 45 has been sutured into place or otherwise attachedto the frame, the overhang 80 is folded back away from the frame, asshown on the second side 143 of the frame of FIG. 26A, and part of theexcess overhang 80 is trimmed away with a scalpel 159 or other cuttinginstrument to leave a 2-4 mm skirt around the frame 11. The overhang 80or skirt provides a free edge of SIS (or material with similarremodeling properties) to help encourage more rapid cell ingrowth fromthe vessel wall, such that the SIS replaces native tissue as quickly aspossible. An unattached edge of the overhang 80 can also form a cornerflap 81 or pocket as depicted in FIG. 27. This corner flap 81 can serveto catch retrograde blood flow 47 to provide a better seal between thedevice 10 and the vessel wall 70 as well as providing an improvedsubstrate for ingrowth of native intimal tissue from the vessel 33, ifmade of SIS or another material with remodeling properties.

Referring now to FIGS. 28-31, the frame 11 used to form the valve 43embodiments, e.g., FIGS. 20-27, that are placed in the legs or otherdeep veins as replacement for incompetent venous valves, is sizedaccording to the size of the target vessel. For example, a typicalvenous valve might be made of 0.0075″ 304 stainless steel mandril wirewith an attachment mechanism 15 comprising 23 to 24 gauge thin-wallstainless steel cannula or other tubing. Larger wire (e.g., 0.01″) andattachment cannula 15 are typically used for valves 43 of the largerdiameter (greater than 15 mm). Selection of the attachment cannula 15depends on competing factors. For example, use of larger gaugeattachment cannula 15 results in a slightly increased device 10 profile,yet it includes additional room for flux when the attachment mechanism15 is soldered over the continuous wire 59 comprising the frame 11. FIG.30 best depicts an uncovered frame 11 used to form a venous valve 43,wherein the length of the sides 13 typically range from about 15 to 25mm. For larger frames, heavier gauge wire is typically used. Forexample, 25 mm frames might use 0.01″ wire, with larger diameterembodiments such as stent occluders used for femoral bypass or stentadaptors, such as shown in FIGS. 17 and 32, requiring an even heaviergauge. The appropriate gauge or thickness of the frame wire also dependson the type of alloy or material used. As previously disclosed, theframe is typically formed in a generally flat configuration and thenmanipulated into its characteristic serpentine configuration and loadedinto a delivery system. Therefore, the frame usually will tend toreassume the first or generally flat configuration if the restraint ofthe delivery system or vessel is removed. Deformation of the frame 11can occur after it has been manipulated into the second configuration,however, such that it no longer will lie completely flat, as depicted inFIG. 34. This angle of deformation 129, which varies depending on theframe thickness and material used, generally does not compromise thefunction of the device 10, which can be reconfigured into the serpentineconfiguration (of the second, deployed configurations) without loss offunction.

The frame 11 of the present invention can be made either by forming aseries of bends in a length of straight wire and attaching the wire toitself, as previously discussed, to form a closed configuration, or theframe 11 can be formed in the deployment (second) configuration 35 asdepicted in FIGS. 41-41A by cutting it out of a flat sheet 152 ofmaterial, e.g., stainless steel or nitinol. Further finishing procedurescan then be performed after it has been cut or formed, such aspolishing, eliminating sharp edges, adding surface treatments orcoatings, etc. In addition to metal, the frame 11 can comprise one ormore polymers, composite materials, or other non-metallic materials suchas collagen with the frame either being cut from a thin sheet of thematerial, or molded into the deployment configuration 36 as depicted inFIG. 43. Unlike the majority of the depicted embodiments, the frame 11of FIG. 43 does not naturally assume a flattened configuration 35 whenthe device 10 is unconstrained by the vessel or delivery system.

The illustrative embodiments of FIGS. 41-41A and 43 include integralbarbs 124 that extend from the frame 11, which being formed as a closedframe, does not have free ends 60,61 that can be used to serve as barbs16 as depicted in FIG. 3 and other embodiments. FIGS. 41-41A depict aseries of integral barbs 124 comprising V-shaped cuts 139 transversingthe thickness of the flat metal frame 11, which are bent outward to formthe barb 16. In the embodiment of FIG. 43, the integral barbs 124 areformed along with the frame 11 with two extending from the frame ateither side of each bend 12. These integral barbs 124 can be designedinto the mold if the frame 11 is formed out of a polymer material. Thenumber, arrangement, and configuration of the integral barbs 124 isgenerally not critical and can vary according to design preference andthe clinical use of the device. The barbs 16 may or may not penetratethe covering, depending on their design and other factors, including thethickness and type of covering used.

While the frame embodiment of FIG. 43 can be formed from a variety ofmedical grade polymers having properties that permit the frame tofunction as a supporting structure for the valve leaflets 78,79, itshould be noted that for some uses, it may be desirable to form theframe 11 from a material that can be degraded and adsorbed by the bodyover time to advantageously eliminate a frame structure can would remainin the vessel as a foreign body and that could possibly fracture and/orcause perforation of the vessel wall. A number of bioabsorbablehomopolymers, copolymers, or blends of bioabsorbable polymers are knownin the medical arts. These include, but are not necessarily limited to,poly-alpha hydroxy acids such as polyactic acid, polylactide,polyglycolic acid, or polyglycolide; trimethlyene carbonate;polycaprolactone; poly-beta hydroxy acids such as polyhydroxybutyrate orpolyhydroxyvalerate; or other polymers such as polyphosphazines,polyorganophosphazines, polyanhydrides, polyesteramides,polyorthoesters, polyethylene oxide, polyester-ethers (e.g.,polydioxanone) or polyamino acids (e.g., poly-L-glutamic acid orpoly-L-lysine). There are also a number of naturally derivedbioabsorbable polymers that may be suitable, including modifiedpolysaccharides such as cellulose, chitin, and dextran or modifiedproteins such as fibrin and casein.

FIGS. 44-46 depicts two exemplary embodiments in which the frame 11 isintegral with the covering 45. In the embodiment of FIG. 44, the valve43 is formed as a single piece of material, such as a flexible polymericor collagen-based material, whereby there is a thin, compliant centralportion comprising the covering 45 or leaflets 78,79, and a thickenededge 141 portion that comprises the frame 11. The valve 43, shown in thegenerally flat configuration 35, can be also formed into the deploymentconfiguration 36 (see FIG. 43). Optionally, the material of the frame 11portion can be subjected to treatments or processes that add rigidity orother desired characteristics that permit the frame to better supportthe covering 45 portion or anchor the device 10 to the vessel wall. Aswith the embodiment of FIG. 43, optional intergral barbs 124 can beincluded along the frame 11. In addition to forming a thickened edge 141to serve as the frame 11, other layers of different materials can belaminated to or blended with the edge portion to provide the desiredproperties. As another alternative to the thickened edge 141 portion ofFIGS. 44-45, the outside edge 112 of the covering 45 can be folded overitself to form a rolled edge 140 (FIG. 46) that adds rigidity to serveas a frame 11. The rolled edge 140 can be held in placed with a glue,resin, or similar bonding agent 144. For example, the covering 45 androlled edge 140 can comprise a sheet of SIS with a bonding agent 144such as collagen glue or other bioabsorbable material used to secure therolled portion and after hardening, to add the necessary degree ofrigidity for the valve 43 (or occluder, filter, stent adaptor, etc.) toassume the deployment configuration within the vessel. Excess of thebonding agent 144 can be fashioned to structural elements that can serveto help anchor the device 10 within the vessel. It is also within thescope of the invention to eliminate a discernable frame 11 by changingthe material or material properties along the outer edge 112 of theleaflets, by adding or incorporating one or more different material oragents along the outer edge 112 of covering 45 such that the stiffnessand/or resiliency increased, thereby allowing the frame to hold adesired shape during deployment, while still allowing the adjacentcovering material to be sufficiently flexible to function as a leaflet25. If the illustrative valve 43 lacks the radial expandability toanchor itself to the vessel wall, it may be mounted on a balloon toexpand the valve 43 and anchor the barbs, if present, into the vesselwall.

The illustrative embodiments of the present invention generally includea closed frame 11 to give the device 10 its form. FIG. 47 depicts anexample in which the frame 11 portion is not a closed structure. Rather,a portion of the covering 45 used to span a gap 145 in the frame suchthat a portion of the outside edge 112 (of leaflet 79 in this example)is unsupported therealong. The length of the gaps 145 and theirdistribution can vary as long as the frame 11 is still able to fulfillits role to support and define the shape of the valve 43 or device 10.

FIGS. 21-31 depict various embodiments in which the bends 20,21,22,23are placed in a resiliently tensioned or stressed state after beinginitially formed such that the bends were not under tension. Theterm >tension=, as used herein, is meant to describe generally a forcedapplied to a resilient material or structure against the naturaltendency of the material or structure, whether or not the force is infact tensile, compression, or torsional. Further incremental forcesapplied will generally encounter greater resistance than would otherwisebe exhibited by the material or structure, such as a compression spring,which exerts a force (resilience) resisting compression proportional tothe distance the spring has already been compressed. The addition oftension to one or more bends 12 of the device frame 11 can alter theproperties of the frame 11 and result in improved sealingcharacteristics or the ability of the device 10 to impinge upon thevessel wall 70 to prevent migration or shifting. In the illustrativeembodiments, the coil turn 14 is formed as previously disclosed wherebyeach bend 12 is in a untensioned state with the adjacent sides 13 havingan initial angle after formation of the bend 12. For example, in theembodiment of FIG. 20, the initial angle 109 after the bends are formedand the final angle 110 after the frame 11 is assembled are bothapproximately 90□. Therefore, the bends 12 of the embodiment of FIG. 20are not placed under any significant degree of tension. In theembodiments of FIGS. 21-31, the frame is restrained to permanently placethe bends 12 under tension such that the angle between the sides 122,123adjacent to the bend 12 is increased or decreased by some method ofmanipulation to produce a resiliently tensioned bend 118 (FIGS. 26 and29) having a final angle 110 different than the initial angle 109 (e.g.,FIG. 28).

Referring particularly to FIGS. 21-28, the covering 45 (including a fullor a partial covering 58) can be attached to the frame 11 of the valve43 or other embodiment of the present invention, to constrain agenerally untensioned square frame 11 (such as in FIG. 1) andsubsequently form an altered shape 82, such as a diamond 153, in whichthe distance between bends 20 and 21 is lengthened and the distancebetween bends 22 and 23 is shortened. By way of example, and using FIG.21 as reference, the angle 110 measured between the adjacent sides 13from bends 20 and 21 might decrease to 70-80□ with a increase in thecorresponding angles 161 measured at bends 22 and 23 to 100-110□. Thismanipulation of the frame 11 shape serves to add tension in each of thebends, which allows better positioning of the device 10 against thevessel wall 70 while in the deployed configuration, as shown in FIGS.22-25. Additionally, constraining the frame 11 along the first axis 94of the slit 108 allows that distance 146 to be adjusted to provide theoptimum size for the vessel 33 into which the valve 43 is to beimplanted. Assuming a resilient frame 11 is being used that makes thevalve 43 radially expandable, it would normally be preferential toslightly oversize the valve 43 along at the width 146 of the frame 11(along first axis 94) when the valve 43 is in the generally flattenedconfiguration 35, thereby causing the leaflets 78,79 to relax slightlywhen the valve 43 is in the deployed configuration 36 and beingconstrained slightly by the vessel 33. The proper length of theconstrained frame 11 as measured diagonally between bends 22 and 23 iscalculated such that the leaflets 78,79 open by an effective amount inthe presence of blood flow 46 that most closely mimics that found in anormal functioning valve.

Dog studies by Karino and Motomiya (Thrombosis Research 36: 245-257)have demonstrated that there is about a 60 to 70% constriction of bloodflow through the natural valve. In the valve 43 of the presentinvention, the leaflets 25 should ideally span about 30-60% of thevessel 33 diameter across. If it is much less than 30%, blood flow 46may be impeded to an unacceptable degree, while if the leaflets 78,79are allowed to fully open, they can adhere to the vessel wall 70 andtherefore, not close properly in the presence of retrograde flow 47. Theframe 11 can be formed or constrained such that the distance 146 betweenpoints 22,23 lies between πr, which would allow the valve to open to thefull extent that the vessel allows, and 2 r in which the valve 43 isstretched tight across the frame 11 and is very limited in the amount ofblood that will allow to pass through. To give the leaflets theflexibility and compliance to open to permit flow and then close to sealagainst backflow, the slit axis distance 146 of the valve 43 should beoversized with respect to the diameter of the vessel into which it is tobe placed. Constraining the valve 43 along the first axis 94 such thatit sized a few mm larger than the lower extreme (2 r) or a few mm largerthan the upper extreme (πr), not only allows the leaflets to function ina more optimal manner, but also allows the valve 43 to safely andeffectively impinge on the vessel wall to seal and reduce thepossibility of migration. The ideal amount of oversize is largelydependent on the size and diameter of the frame 11 prior to resizing.FIG. 49 depicts a schematic top view of the valve of FIG. 22 showing thelength 147 of the orifice, the width 148 of the orifice, the portion 154of the vessel occluded by a leaflet 25, and the corner gaps 155 thanexist between each lateral edge 156 of the valve orifice 117 and theouter edge 112 of the leaflet 25 (or the frame 11). The followingformula can be to approximate the elliptic circumference (C) of thevalve orifice 117, where a=one half the length 147 of the orifice, andb=one half the width 148 of the orifice 117:

Assuming that we wish to size the valve 43 to produce an orifice 117that opens approximately 30-60% of the vessel lumen 34 (with theoccluded portions 154 comprising 40-70% of the same), the precedingformula can be used to determine the amount of oversize that producesthe desired characteristics. The amount of oversize (valve width 146 inthe flat configuration minus the diameter of the vessel lumen 34) wouldgenerally range from 1-2 mm for smaller valves (those placed in 8-9 mmvessels) up to 3-4 mm for valves intended for larger vessels (17-21 mm).For example, a valve intended for a 14 mm vessel should ideally have a2-3 mm oversize if the range of 30-60% opening is to be maintained. Ifthe frame 11 of a valve 43 having 20 mm sides is constrained such thatthe distance between bends 22 and 23 is adjusted to approximately 16 mm,the valve 43 opens approximately 43%, which is well within the mostdesired range. If constrained to 17 mm, the valve 43 is able to open upto approximately 55% of the vessel diameter. In contrast, oversizing thevalve 43 by 6 mm, produces a large orifice 117 of 83% which lies outsidethe target range, although it would certainly produce a valve 43 capableof opening and closing in response to fluid flow 46,47. To produce avalve 43 in which the valve width in the generally flattenedconfiguration 35 is 17-18 mm, which would be a valve 43 sized toaccommodate a 14-15 mm vessel, the 20 mm frame 11 should be constrainedsuch that the distance between bends 22 and 23 is 15 mm prior toaddition of the covering 45, if a compliant material such as SIS isused. As depicted in FIG. 26, the frame 11 is constrained across thefirst axis 94 using a temporary constraining mechanism 121, such as bytying a suture through the coil turns 14 of bends 22 and 23 to pull themtoward one another until a distance of 15 mm is reached. After thecovering 45 has been attached, such as by the method previouslydisclosed, the temporary constraining suture 121 is cut, which resultsin a slight expansion in the width of the frame 11 as the SIS stretchesunder the tension of the constrained frame, resulting in the desiredfinal width of 17-18 mm. The amount of expansion varies with thecompliance of the particular covering 45 as well as the resiliency ofthe frame 11. Although the desired final width 146 of the constrainedframe 11 can result from a relatively wide range of initial frame 11sizes, depending on how much the frame is constrained, generally, largersized frames (e.g., sides measuring about 25 mm) are most suitable forlarger vessels (e.g., 16-21 mm in diameter), while smaller frames (e.g.,15 mm) are most suitable for smaller diameter vessels (e.g., 8-9 mm).While this range represents the most common sizes used for correctingvenous valve insufficiency in the lower legs, valves 43 of the presentinvention can be made in a much larger range of sizes to treat veins orother vessels elsewhere in the body.

FIGS. 28-31 depict another embodiment of the present invention in whicha open frame 11, such as depicted in FIG. 28, is assembled into a squareframe (FIGS. 29-31) such the bends 12 are put under tension. Theresiliently tensioned bends 118 in the assembled device (as shown inFIGS. 29-31) result from the initial angle 109 formed in wire frame 11before being assembled into a closed circumference 62 (FIG. 28), beinggreater than the final angle 110. To form the embodiment of FIG. 1, forexample, the wire is wrapped around a pin to form the coil turns 14 withthe sides 13 generally lying about 90□ with respect to one another. Theattachment mechanism 15 then secures and closes the frame 11 to form thefinal square shape. In the embodiments of FIGS. 28-31, the first angle109 is made approximately 150□, rather than 90═, which is the desiredfinal angle 110. While the wire is not under stress after the bends 12are initially formed, the bends 12 and sides 13 are stressed when thedevice 10 is constrained during assembly to form the four-sided,generally square shape. In particular reference to FIG. 30, the sides122,123 adjacent to a resiliently tensioned bend 118 becomes somewhatdeformed when the bend 12 is put under stress, generally assuming abowed shape between the adjacent bends. By creating this >roundedsquare=with tensioned or stressed bends 118, the sides 13 of the frame11 are able to better conform to the rounded vessel wall 70 than would aside 13 that is initially straight prior to deployment. Additionally, byrounding the distal bends 116 of the valve legs 113, it may also reducethe potential for the valve legs 113 to cause trauma to the vessel 33 asthey continue to exert force thereupon.

An additional method of constraining the valve 43, or similar typedevice 10 (e.g., occluder, filter, stent, stent adaptor), is depicted inFIG. 48 in which a circumferentially constraining mechanism 125, isadded to at least partially encircle the frame 11 while it is in boththe delivery configuration 37 (FIG. 6) and the deployed configuration 36such that the device 10 is limited in its ability to radially expand.Once the device reaches its maximal radial expansion, the outward forcethe device 10 places on the vessel wall 70 is eliminated, therebyreducing potential damage thereto (e.g., from an improperly sizedvalve), such as tissue erosion possibly resulting in eventualperforation of the vessel 33. In the illustrative embodiment, thecircumferentially constraining mechanism 125 comprises a suture that isaffixed to and completely encircles the frame 11 to limit the outwardexpansion of the valve legs 127,128. The sides 13 of the valve legs127,128 include an intermediate coil turn 126, also illustrated in FIG.39 fulfilling a different function, that provides an effectiveattachment point through which to feed and/or affix the suture restraint125. In the illustrative embodiment, the suture restraint 125 is in arelaxed state when the device 10 is loaded in the delivery system. Then,as the device 10 is deployed, it expands within the vessel 33 until itis constrained by the suture restraint 125 if the device 10 has beenproperly sized such that vessel 33 does not provide constraining forcessufficient to prevent the device 10 from fully expanding to itspredetermined maximum diameter. If the device is undersized for thediameter of the vessel, it may be subject to migration due toinsufficient expansion. The illustrative embodiment is merely exemplaryof the numerous available circumferentially constraining mechanisms 125.It is not necessary that the circumferentially constraining mechanism125 completely encircle the device 10. For example, short pieces ofsuture or another type of tethering mechanism, such as a section ofwebbing or other material, can be affixed between the sides of the valvelegs to limit their expansion, or the frame can include an integralcircumferentially constraining mechanism, such as an expandable strutformed as part of the frame. The strut would unfold as the frameradially expands and limits how far the sides of the valve leg to whichis attached, can spread apart relative to each other, thereby limitingthe outward radial force from the device against the vessel wall.

Another possibility is for circumferentially constraining mechanism 125to comprise a sleeve 162 of flexible material, such as SIS around thevalve 43, as depicted in FIG. 50, which is of a diameter appropriate fordeployment within the target vessel 33 (typically, being slightly largerthan the target vessel diameter) that allows the valve to anchorthereto. The sleeve 162 could be affixed to the frame 11 with sutures 50or by some other means as the valve 43 is held in a collapsed conditionprior to loading the device 10, including the sleeve 162, into adelivery system. The sleeve 162 enclosed the length of the valve 43, orthe bends 12 and barbs 16 can be left uncovered, as shown. To reduceresiliency of the sleeve 162, tethers and other types ofcircumferentially constraining mechanism 125 can be used in combinationwith the sleeve 162 to limit radial expandability of the valve 43. Itshould be noted that if the circumferentially constraining mechanism 125itself is a resilient member, it will only serve to reduce the outwardforce of the device 10 against the vessel wall 70 until maximumexpansion is reached.

FIGS. 30-31 depict alternative methods of forming the frame 11 andattaching barbs thereto. In the embodiment shown in FIG. 30, attachmentmechanisms 15,85 and 84,86, per side rather than a single cannula asshown in previous embodiments, such as FIG. 29. Rather than placing theattachment mechanisms 15 at the point 87 where the respective ends 60,61of the wire frame 11 cross to form the square shape, two attachmentmechanisms 15,85 are placed on either side of the cross point 87. Havingan additional attachment mechanism 84,85,86 on a side 13 provides betterfixation of the frame with little additional metal and helps preventtwisting of the frame 11. On the opposite side which contains the doubleended barb 39, the double attachment mechanisms 84,86 arrangementprovides a similar function. In the embodiment of FIG. 31, threeattachment mechanisms 15,85,88 and 84,86,89, are used per side whichprovide better fixation of the frame 11 as well as serving as attachmentpoints for including supplemental barbs 90,91,92,93 to provide a moresecure anchoring of the device 10 to the vessel wall 70. Theillustrative barbs 16 are typically configured such that they extendonly a short distance (less than 1-2 mm) beyond the bends 12; however,the barbs 16 can be made virtually any practical length, such asextending them more than 1 cm beyond the bends 12 to aid in stabilizingthe device 10 upon deployment such that it does not shift laterally andend up being cockeyed within the vessel. To assist in this function, thebarbs can be shaped accordingly, rather than be limited to asubstantially straight configuration.

The present invention is not limited to a two-leaflet valve 43 (ortwo-leg occluder or stent adaptor, etc.). FIGS. 35-40 depictmulti-leaflet valves 43 having three or four valve legs 113 and leaflets25. The addition of additional leaflets reduces the load produced by thefluid column upon each individual leaflet 25. This in turn, puts lessstress upon the sutures or attachment points of the covering 45, therebyallowing the valve 43 to function under higher pressures than wouldotherwise be possible. For example, these valves 43 could proveadvantageous for use on the arterial side, such as to augment pulmonaryvalves, or within the heart itself, where pressures exerted on theleaflets can be significantly higher than normally found on the venousside. FIG. 35 depicts a valve 43 which in the generally flattenedconfiguration 35, has a three legs 127,128,130 that lie approximately120□ with respect to one another. The respective leaflets are arrangedsuch that the inner edges 111 thereof, define a triangular-shaped valveorifice 117. When the illustrative valve 43 is placed in the vessel 33for which it has been properly sized, as depicted in FIG. 37, theleaflets 78,79,119 are able to close against one another to seal thevalve. The concept of adding additional legs 113 to distribute the loadover a larger number of attachment points 50 (e.g., sutures) and addpositional stability to the device 10, can be applied to occluders andstent adaptors as well.

One method of forming the embodiment of FIG. 35, involves constructing atriangular-shaped frame 1, as shown in FIG. 36, that includes anintermediate coiled eyelet 132 formed at the midpoint of each of thethree sides 13. A temporary constraining suture 121, such as that shownin FIG. 38, is threaded through each of the intermediate eyelets 132,drawing them inward to form three additional bends 133,134,135 formingthree legs 127,128,130 of a desired shape (FIG. 35), depending howtightly the constraining suture 121 is drawn. At this point, thecovering 45 is attached to the frame 11, either as three separateleaflets 78,79,119, or a single piece through which thetriangular-shaped valve orifice 117 is formed. After the covering 45 hasbeen secured to the frame 11, the constraining suture 121 is cut andremoved. As depicted, the barbs 16 are affixed to the triangular shapedframe of FIG. 36, two per side, such that they terminate on either sideof intermediate eyelet 132. Thus, when the intermediate eyelets 132 aredrawn inward to create six sides 13, each includes a barb 16.

The embodiment of FIGS. 38-40, which includes four legs 127,128,130,131,is formed in a similar manner to that of the embodiment of FIGS. 35-37.The frame 11 is initially formed in a square configuration (FIG. 39)with intermediately placed coiled eyelets 132 at the midpoint of eachside 13, dividing the side into a first and second side portion 137,138.As depicted in FIG. 38, the temporary constraining suture 121 is used todraw the eyelets inward where they form the four additional bends133,134,135,136 such that four valve legs 127,128,130,131 are formedwith the first and second sides portions 137,138 becoming sides 13 ofadjacent valve legs 127,128. A square-shaped valve orifice 117 iscreated when the four leaflets 78,79,119,120 are attached to the legs127,128,130,131 of frame 11. One should appreciate that valves with morethan four legs would be made in a similar manner to the embodimentsabove with a five-sided valve being formed from a pentagon, a six-sidedvalve being formed from a hexagon, etc.

Delivery of the device 10 of the present invention can be accomplishedin a variety of ways. One method, depicted in FIG. 33, involves the useof a delivery system 103 similar to that used to deliver embolizationcoils. The delivery system 103 comprises an outer member 105, such as acannula or catheter, and an coaxial inner member 105 that includes atethering tip 107, such as a notched cannula, adapted to receive a barb17 extending from the frame 11. The tip 104 of the barb is configuredsuch that it can positively engage with the tethering tip 107. This canbe accomplished by adding a projection, such as a secondary barb, hook,spine, etc. to the tip 104, or otherwise enlarging the diameter thereofsuch that it can be releasably secured by the tethering tip 107 untildeployment. The coaxial inner member 106 also includes an outer sheath149 that retains and the locks the barb tip 104 within the tethering tip107 until it is advanced or retracted by manipulation of a proximalhandle (not shown) to expose the notch 150 in the tethering tip, whichreleases the barb 17 and deploys the device 10. The device 10 ispreloaded within the outer member 105. The coaxial inner member 106 andattached device 10 are then advanced together from the outer member 106at the target site. Further manipulation of the proximal handle,advances the tethering tip 107, which in this particular embodiment,includes a coiled spring 151, relative to the outer sheath 149. Afterthe device 10 has been released from the tethering tip 107, thespring-activated handle is released and the outer sheath 149 slides backover the tethering tip 107. The coaxial inner member 106 is withdrawninto the outer member 105 and the entire delivery system 103 is removedfrom the patient. As shown in FIG. 33, the barb tip 104 extends justbeyond the coil turn 14 of the frame 11 so as to have sufficient room toengage with the coaxial inner member 106. The barb tip 104 must bepositioned to account for whether the device 10 is to be placed using afemoral approach or a superior approach.

The illustrative delivery system 103 represents only one of manypossibilities. For example, the device 10 can be attached to a deliverydevice using screws, clips, magnets, or some other tethering mechanism,or can be deployed by applying electrical current, heat, or some othermeans to cause detachment with a carrying mechanism. As previouslydisclosed, rather than making the device 10 self-expanding, where it ispushed from some sort tubular device, it can be formed from a ductilematerial, mounted over a balloon or other inflatable or expandabledelivery mechanism, and deployed by expanding the device in that manner.

It is thus seen that the present invention includes devices having anumber of configurations with regard to the frame, covering, barbs, etc.Futhermore, it has been seen that the invention and can be formed in avariety of ways using a different types of medical grade materials, andhas utility to treat a wide range of medical problems. The embodimentscontained herein should be considered merely exemplary as one skilled inthe medical arts would appreciate that further modifications would bepossible that would be included within the spirit of the invention.

1. A device for implantation within a bodily passage comprising: abioabsorbable frame; and at least one leaflet formed by a coveringhaving remodelable properties that is attached to a portion of theframe; wherein the leaflet has a flexible free edge that defines atleast a portion of a valve orifice.
 2. The device for implantationwithin a body passage of claim 1, wherein the flexible free edge is anouter body edge of the leaflet.
 3. The device for implantation within abody passage of claim 1, wherein the leaflet has an arcuate shape. 4.The device for implantation within a body passage of claim 1, whereinthe flexible free edge at least partially opens in response to forceexerted by a fluid traveling in a first direction within a bodilypassage.
 5. The device for implantation within a body passage of claim1, wherein the frame is formed integrally with the covering.
 6. Thedevice for implantation within a body passage of claim 1, wherein theframe is moveable between a deployed configuration and a compresseddelivery configuration.
 7. The device for implantation within a bodypassage of claim 6, wherein the frame in the deployed configurationassumes a serpentine configuration.
 8. The device for implantationwithin a body passage of claim 1, wherein the frame further comprises ameans for anchoring the device in the lumen of a body passage.
 9. Thedevice for implantation within a body passage of claim 1, wherein theframe further comprises one or more barbs.
 10. The device forimplantation within a body passage of claim 1, wherein the material withremodeling properties is an extracellular matrix material.
 11. Thedevice for implantation within a body passage of claim 10, wherein theextracellular matrix material is selected from the group consisting of:small intestine submucosa, pericardium, stomach submucosa, liverbasement membrane, urinary bladder submucosa, tissue mucosa and duramater.
 12. The device for implantation within a body passage of claim 1,wherein the material with remodeling properties is small intestinesubmucosa.
 13. The device for implantation within a body passage ofclaim 1, wherein the bioabsorbable material is selected from the groupconsisting of: poly-alpha hydroxyl acid, trimethylene carbonate,polycaprolactone, poly-beta hydroxyl acid, polyphosphazine,polyorganophosphazine, polyanhydride, polyesteramide, polyorthoester,polyethylene oxide, polyester-ether and polyamino acid.
 14. The devicefor implantation within a body passage of claim 1, wherein thebioabsorbable material is polyacetic acid, polylactide, polyglycolicacid or polyglycolide.
 15. The device for implantation within a bodypassage of claim 1, wherein the bioabsorbable material ispolyhydroxybutyrate, polyhydroxyvalerate or a polydioxanonepolyester-ether.
 16. The device for implantation within a body passageof claim 1, wherein the bioabsorbable material is poly-L-glutamic acidor poly-L-lysine.
 17. The device for implantation within a body passageof claim 1, wherein the bioabsorbable material is a modifiedpolysaccharide, fibrin or casein.
 18. The device for implantation withina body passage of claim 1, wherein the bioabsorbable material iscellulose, chitin or dextran.
 19. A valve for implantation within a bodypassage, comprising: a bioadsorbable frame, and two or more leaflets,wherein each leaflet is formed by a covering having remodelableproperties that is attached to one or more portions of the frame;wherein each leaflet has a flexible free edge, and wherein each flexiblefree edge of each leaflet meets to cooperably define an opening.
 20. Tevalve of claim 19, wherein the valve has two leaflets.
 21. The valve ofclaim 19, wherein the valve has three leaflets.
 22. The valve of claim19, wherein the covering with remodelable properties is an extracellularmatrix material.
 23. The valve of claim 19, wherein the bioabsorbableframe comprises a material selected from the group consisting of:poly-alpha hydroxyl acid, trimethylene carbonate, polycaprolactone,poly-beta hydroxyl acid, polyphosphazine, polyorganophosphazine,polyanhydride, polyesteramide, polyorthoester, polyethylene oxide,polyester-ether and polyamino acid.
 24. A device for implantation withina body passage comprising: a single frame having two or more sides, theframe formed into two or more legs and comprised of a bioabsorbablematerial; a covering attached to at least two sides of a first leg toform a body of a first leaflet, the covering comprising a material withremodeling properties; the first leaflet having an inner body edge andan outer body edge; and wherein the inner body edge of the first leafletis a flexible free edge that defines at least a portion of a valveorifice.
 25. The valve for implantation within a body passage of claim24 wherein the inner body edge of the first leaflet and the inner bodyedge of the second leaflet are sufficiently flexible to move apart inresponse to fluid flow through the valve orifice in a first direction.26. The valve for implantation within a body passage of claim 25 whereinthe inner body edge of the first leaflet is cooperable with the innerbody edge of the second leaflet to substantially prevent retrogradefluid flow in a second direction that is opposite the first direction.27. The valve for implantation within a body passage of claim 24 whereinthe material with remodeling properties is an extracellular matrixmaterial.
 28. The valve for implantation within a body passage of claim24 wherein the extracellular matrix material is selected from the groupconsisting of: small intestine submucosa, pericardium, stomachsubmucosa, liver basement membrane, urinary bladder submucosa, tissuemucosa and dura mater.
 29. The valve for implantation within a bodypassage of claim 24, wherein the material with remodeling properties issmall intestine submucosa.
 30. The valve for implantation within a bodypassage of claim 24, wherein the bioabsorbable material is selected fromthe group consisting of: poly-alpha hydroxyl acid, trimethylenecarbonate, polycaprolactone, poly-beta hydroxyl acid, polyphosphazine,polyorganophosphazine, polyanhydride, polyesteramide, polyorthoester,polyethylene oxide, polyester-ether and polyamino acid.
 31. The valvefor implantation within a body passage of claim 24, wherein thebioabsorbable material is polyacetic acid, polylactide, polyglycolicacid or polyglycolide.
 32. The valve for implantation within a bodypassage of claim 24, wherein the bioabsorbable material is apolydioxanone polyester-ether, polyhydroxybutyrate orpolyhydroxyvalerate.
 33. The valve for implantation within a bodypassage of claim 24, wherein the bioabsorbable material ispoly-L-glutamic acid or poly-L-lysine.
 34. The valve for implantationwithin a body passage of claim 24, wherein the bioabsorbable material isfibrin, casein or a modified polysaccharide.
 35. The valve forimplantation within a body passage of claim 24, wherein thebioabsorbable material is cellulose, chitin or dextran.
 36. A valve forimplantation within a body passage comprising: a single frame having twoor more sides, the frame formed into two or more legs and comprised of abioabsorbable material; a covering attached to at least two sides of afirst leg to form the body of a first leaflet, the covering comprising amaterial with remodeling properties; the first leaflet having a firstinner body edge and a first outer body edge; wherein the first innerbody edge of the first leaflet is a first flexible free edge thatdefines at least a portion of a valve orifice; the covering attached toat least two sides of a second leg to form the body of a second leaflet,the covering comprising a material with remodeling properties; thesecond leaflet having a second inner body edge and a second outer bodyedge; and wherein the second inner body edge of the second leaflet is asecond flexible free edge that defines at least a portion of the valveorifice.
 37. A valve for implantation within a body passage comprising:a single frame having two or more sides, the frame formed into three ormore legs and comprising a bioabsorbable material; a covering attachedto at least two sides of a first leg to form the body of a firstleaflet, the covering comprising a material with remodeling properties;the first leaflet having a first inner body edge and a first outer bodyedge; wherein the first inner body edge is a first flexible free edgethat defines at least a portion of a valve orifice; the coveringattached to at least two sides of a second leg to form the body of asecond leaflet, the covering comprising a material with remodelingproperties; the second leaflet having a second inner body edge and asecond outer body edge; and wherein the second inner body edge is asecond flexible free edge that defines at least a portion of the valveorifice; and the covering attached to at least two sides of a third legto form the body of a third leaflet, the covering comprising a materialwith remodeling properties; the third leaflet having a third inner bodyedge and a third outer body edge; and wherein the third inner body edgeis a third flexible free edge that defines at least a portion of thevalve orifice.
 38. The device for implantation within a body passage ofclaim 37 wherein the first inner body edge, the second inner body edge,and the third inner body edge, are sufficiently flexible to move apartin response to fluid flow through the valve orifice in a firstdirection.
 39. The device for implantation within a body passage ofclaim 37, wherein the first inner body edge is cooperable with thesecond inner body edge of the second leaflet and the third inner bodyedge to substantially prevent retrograde fluid flow in a seconddirection that is opposite the first direction.
 40. The device forimplantation within a body passage of claim 37 wherein the material withremodeling properties is an extracellular matrix material.
 41. Thedevice for implantation within a body passage of claim 37, wherein theextracellular matrix material is selected from the group consisting of:small intestine submucosa, pericardium, stomach submucosa, liverbasement membrane, urinary bladder submucosa, tissue mucosa and duramater.
 42. A valve for implantation within a body passage comprising: asingle frame having two or more sides, the frame formed into two or morelegs and comprising a bioabsorbable material; wherein the bioabsorbablematerial is selected from the group consisting of: polyacetic acid,polylactide, polyglycolic acid, polyglycolide, trimethylene carbonate,polycaprolactone, polyhydroxybutyrate, polyhydroxyvalerate,polyphosphazine, polyorganophosphazine, polyanhydride, polyesteramide,polyorthoester, polyethylene oxide, polyester-ether, poly-L-glutamicacid, poly-L-lysine, cellulose, chitin, dextran, fibrin and casein; acovering attached to at least two sides of a first leg to form a body ofa first leaflet, the covering comprising a material with remodelingproperties; wherein the material with remodeling properties is anextracellular matrix material selected from the group consisting of:small intestine submucosa, pericardium, stomach submucosa, liverbasement membrane, urinary bladder submucosa, tissue mucosa and duramater; the first leaflet having a first inner body edge and a firstouter body edge; wherein the first inner body edge of the first leafletcomprises a first flexible free edge that defines at least a portion ofa valve orifice. the covering is attached to at least two sides of asecond leg to form a body of a second leaflet, the covering comprising amaterial with remodeling properties; the second leaflet having a secondinner body edge and a second outer body edge; wherein the second innerbody edge comprises a second flexible free edge that defines at least aportion of the valve orifice; the first flexible free edge and thesecond flexible free edge are sufficiently flexible to move apart inresponse to fluid flow through the valve orifice in a first direction;the first inner body edge is cooperable with second the inner body edgeto substantially prevent retrograde fluid flow within a body vessel in asecond direction that is opposite the first direction; wherein the firstouter body edge has an arcuate shape; wherein the frame is moveablebetween a deployed configuration and a compressed deliveryconfiguration; and wherein the frame comprises one or more barbs.